• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

自动灌装设备能够在保持分散性的同时,增加独眼巨人高剂量干粉吸入装置的最大灌装剂量。

Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops High Dose Dry Powder Inhalation Device While Maintaining Dispersibility.

作者信息

Sibum Imco, Hagedoorn Paul, Botterman Carel O, Frijlink Henderik W, Grasmeijer Floris

机构信息

Department of Pharmaceutical Technology and Biopharmacy, Faculty of Science and Engineering, University of Groningen, 9700 AB Groningen, The Netherlands.

出版信息

Pharmaceutics. 2020 Jul 9;12(7):645. doi: 10.3390/pharmaceutics12070645.

DOI:10.3390/pharmaceutics12070645
PMID:32659899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7407802/
Abstract

In recent years there has been increasing interest in the pulmonary delivery of high dose dry powder drugs, such as antibiotics. Drugs in this class need to be dosed in doses far over 2.5 mg, and the use of excipients should therefore be minimized. To our knowledge, the effect of the automatic filling of high dose drug formulations on the maximum dose that can be filled in powder inhalers, and on the dispersion behavior of the powder, have not been described so far. In this study, we aimed to investigate these effects after filling with an Omnidose, a vacuum drum filler. Furthermore, the precision and accuracy of the filling process were investigated. Two formulations were used-an isoniazid formulation we reported previously and an amikacin formulation. Both formulations could be precisely and accurately dosed in a vacuum pressure range of 200 to 600 mbar. No change in dispersion was seen after automatic filling. Retention was decreased, with an optimum vacuum pressure range found from 400 to 600 mbar. The nominal dose for amikacin was 57 mg, which resulted in a fine particle dose of 47.26 ± 1.72 mg. The nominal dose for isoniazid could be increased to 150 mg, resulting in a fine particle dose of 107.35 ± 13.52 mg. These findings may contribute to the understanding of the upscaling of high dose dry powder inhalation products.

摘要

近年来,人们对高剂量干粉药物(如抗生素)的肺部给药越来越感兴趣。这类药物的给药剂量需要远远超过2.5毫克,因此应尽量减少辅料的使用。据我们所知,高剂量药物制剂的自动填充对粉吸入器可填充的最大剂量以及粉末的分散行为的影响,迄今为止尚未见报道。在本研究中,我们旨在研究使用Omnidose(一种真空转鼓式灌装机)填充后这些影响。此外,还研究了填充过程的精度和准确性。使用了两种制剂——我们之前报道过的异烟肼制剂和阿米卡星制剂。两种制剂在200至600毫巴的真空压力范围内都能精确给药。自动填充后分散情况未见变化。滞留量减少,在400至600毫巴的真空压力范围内发现了最佳值。阿米卡星的标称剂量为57毫克,其细颗粒剂量为47.26±1.72毫克。异烟肼的标称剂量可增加至150毫克,其细颗粒剂量为107.35±13.52毫克。这些发现可能有助于理解高剂量干粉吸入产品的放大生产。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/bda3def21af8/pharmaceutics-12-00645-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/fdd3f79bbbc6/pharmaceutics-12-00645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/f2faecfdeb7e/pharmaceutics-12-00645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/09b72dea01bb/pharmaceutics-12-00645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/9413e373cfda/pharmaceutics-12-00645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/813027ac4634/pharmaceutics-12-00645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/ba16d267c475/pharmaceutics-12-00645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/10b27971960a/pharmaceutics-12-00645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/48f6cbbfb585/pharmaceutics-12-00645-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/2753581c6b18/pharmaceutics-12-00645-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/98da83b9c13f/pharmaceutics-12-00645-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/0560744479ce/pharmaceutics-12-00645-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/bda3def21af8/pharmaceutics-12-00645-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/fdd3f79bbbc6/pharmaceutics-12-00645-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/f2faecfdeb7e/pharmaceutics-12-00645-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/09b72dea01bb/pharmaceutics-12-00645-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/9413e373cfda/pharmaceutics-12-00645-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/813027ac4634/pharmaceutics-12-00645-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/ba16d267c475/pharmaceutics-12-00645-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/10b27971960a/pharmaceutics-12-00645-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/48f6cbbfb585/pharmaceutics-12-00645-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/2753581c6b18/pharmaceutics-12-00645-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/98da83b9c13f/pharmaceutics-12-00645-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/0560744479ce/pharmaceutics-12-00645-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0251/7407802/bda3def21af8/pharmaceutics-12-00645-g012.jpg

相似文献

1
Automated Filling Equipment Allows Increase in the Maximum Dose to Be Filled in the Cyclops High Dose Dry Powder Inhalation Device While Maintaining Dispersibility.自动灌装设备能够在保持分散性的同时,增加独眼巨人高剂量干粉吸入装置的最大灌装剂量。
Pharmaceutics. 2020 Jul 9;12(7):645. doi: 10.3390/pharmaceutics12070645.
2
Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine.L-亮氨酸或三亮氨酸对高剂量异烟肼干粉吸入制剂分散性和储存稳定性的优化
Pharmaceutics. 2019 Dec 25;12(1):24. doi: 10.3390/pharmaceutics12010024.
3
Challenges for pulmonary delivery of high powder doses.高剂量粉末肺部给药的挑战。
Int J Pharm. 2018 Sep 5;548(1):325-336. doi: 10.1016/j.ijpharm.2018.07.008. Epub 2018 Jul 2.
4
Technological and practical challenges of dry powder inhalers and formulations.干粉吸入器及其制剂的技术和实际挑战。
Adv Drug Deliv Rev. 2014 Aug;75:18-31. doi: 10.1016/j.addr.2014.04.004. Epub 2014 Apr 13.
5
Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation.高剂量异烟肼干粉吸入剂的特性及制剂研究
Pharmaceutics. 2019 May 13;11(5):233. doi: 10.3390/pharmaceutics11050233.
6
Dosing challenges in respiratory therapies.呼吸治疗中的剂量挑战。
Int J Pharm. 2018 Sep 5;548(1):659-671. doi: 10.1016/j.ijpharm.2018.07.007. Epub 2018 Jul 2.
7
The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family.用于肺部递送氨基糖苷类药物的独眼巨人;Twincer™ 家族的新成员。
Eur J Pharm Biopharm. 2015 Feb;90:8-15. doi: 10.1016/j.ejpb.2015.01.012. Epub 2015 Jan 20.
8
Dry powders for oral inhalation free of lactose carrier particles.不含乳糖载体颗粒的干粉吸入剂。
Adv Drug Deliv Rev. 2014 Aug;75:32-52. doi: 10.1016/j.addr.2014.04.005. Epub 2014 Apr 13.
9
High dose dry powder inhalers to overcome the challenges of tuberculosis treatment.高剂量干粉吸入器克服结核病治疗的挑战。
Int J Pharm. 2018 Oct 25;550(1-2):398-417. doi: 10.1016/j.ijpharm.2018.08.061. Epub 2018 Sep 1.
10
Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.利福平干粉吸入剂的配方:一种用于肺泡结核病的改良靶向递药系统。
J Aerosol Med Pulm Drug Deliv. 2017 Dec;30(6):388-398. doi: 10.1089/jamp.2017.1379. Epub 2017 May 16.

引用本文的文献

1
WeNet-RF: An Automatic Classification Model for Financial Reimbursement Budget Items.WeNet-RF:一种用于财务报销预算项目的自动分类模型。
PLoS One. 2025 Apr 24;20(4):e0321056. doi: 10.1371/journal.pone.0321056. eCollection 2025.
2
Optimization of Carrier-Based Dry Powder Inhaler Performance: A Review.基于载体的干粉吸入器性能优化:综述
Pharmaceutics. 2025 Jan 13;17(1):96. doi: 10.3390/pharmaceutics17010096.
3
Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler.优化喷雾干燥多孔颗粒以通过便携式干粉吸入器实现高剂量给药。

本文引用的文献

1
Dispersibility and Storage Stability Optimization of High Dose Isoniazid Dry Powder Inhalation Formulations with L-Leucine or Trileucine.L-亮氨酸或三亮氨酸对高剂量异烟肼干粉吸入制剂分散性和储存稳定性的优化
Pharmaceutics. 2019 Dec 25;12(1):24. doi: 10.3390/pharmaceutics12010024.
2
Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation.高剂量异烟肼干粉吸入剂的特性及制剂研究
Pharmaceutics. 2019 May 13;11(5):233. doi: 10.3390/pharmaceutics11050233.
3
Challenges for pulmonary delivery of high powder doses.
Pharmaceutics. 2021 Sep 21;13(9):1528. doi: 10.3390/pharmaceutics13091528.
高剂量粉末肺部给药的挑战。
Int J Pharm. 2018 Sep 5;548(1):325-336. doi: 10.1016/j.ijpharm.2018.07.008. Epub 2018 Jul 2.
4
Powder Flow Testing: Judicious Choice of Test Methods.粉末流动性测试:测试方法的明智选择。
AAPS PharmSciTech. 2017 Jul;18(5):1843-1854. doi: 10.1208/s12249-016-0655-3. Epub 2016 Nov 14.
5
The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.低剂量定量给药胶囊填充过程中材料属性和工艺参数对粉末床均匀性的影响。
Int J Pharm. 2017 Jan 10;516(1-2):9-20. doi: 10.1016/j.ijpharm.2016.11.010. Epub 2016 Nov 5.
6
Recent advances in the fundamental understanding of adhesive mixtures for inhalation.吸入用粘合剂混合物基础认识方面的最新进展。
Curr Pharm Des. 2015;21(40):5900-14. doi: 10.2174/1381612821666151008124622.
7
The Cyclops for pulmonary delivery of aminoglycosides; a new member of the Twincer™ family.用于肺部递送氨基糖苷类药物的独眼巨人;Twincer™ 家族的新成员。
Eur J Pharm Biopharm. 2015 Feb;90:8-15. doi: 10.1016/j.ejpb.2015.01.012. Epub 2015 Jan 20.
8
Low-dose capsule filling of inhalation products: critical material attributes and process parameters.吸入产品的低剂量胶囊填充:关键物料属性和工艺参数
Int J Pharm. 2014 Oct 1;473(1-2):617-26. doi: 10.1016/j.ijpharm.2014.07.050. Epub 2014 Aug 1.
9
The effects of powder compressibility, speed of capsule filling and pre-compression on plug densification.粉末可压缩性、胶囊填充速度和预压对塞子致密化的影响。
Int J Pharm. 2014 Aug 25;471(1-2):182-8. doi: 10.1016/j.ijpharm.2014.04.073. Epub 2014 May 13.
10
Technological and practical challenges of dry powder inhalers and formulations.干粉吸入器及其制剂的技术和实际挑战。
Adv Drug Deliv Rev. 2014 Aug;75:18-31. doi: 10.1016/j.addr.2014.04.004. Epub 2014 Apr 13.